Teva Board News Today

Teva Pharmaceutical Industries Ltd. today announced changes to its leadership team. Sven Dethlefs, Executive Vice President, North America Commercial, will leave Teva on November 17, 2023, and...

TEL AVIV, Israel & PARSIPPANY, N.J., September 28, 2023--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced changes to its leadership team. Sven Dethlefs, Executive Vice President, North America Commercial, will leave Teva on November 17, 2023, and Christine (Chris) Fox, who most recently served as Global President, Gene Therapies at Novartis will be the new head of Teva’s U.S. Commercial Business. "On behalf of the Teva Board of Directors and our executiv...

Teva Announces Appointment of Richard Francis as President and CEO - read this article along with other careers information, tips and advice on BioSpace